Beximco Pharmaceuticals Limited

DSE:BXPHARMA Stock Report

Market Cap: ৳37.9b

Beximco Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Iqbal Ahmed

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure39.9yrs
CEO ownershipn/a
Management average tenure15.6yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Iqbal Ahmed

39.9yrs

Tenure

Mr. Iqbal U. Ahmed is MD of Beximco Pharmaceuticals Limited and serves as its Director since 1985. has been a Director of Shinepukur Ceramics Limited since August 24, 2012 and Non-Executive Director at Ban...

Leadership Team

NamePositionTenureCompensationOwnership
Iqbal Ahmed
MD & Directorno datano datano data
Mohammad Nawaz
Chief Financial Officer15.9yrsno datano data
S. M. Reza
Chief Operating Officer15.6yrsno datano data
Jamal Choudhury
Director of Accounts & Financeno datano datano data
Rizvi Kabir
Director of Marketingno datano datano data
M. A. Bhuiyan
General Manager of Human Resourcesno datano datano data
Zakaria Chowdhury
Head of Distribution Services & Director of International Marketing14.9yrsno datano data
Mohammad Ullah
Company Secretary & Executive Directorno datano datano data

15.6yrs

Average Tenure

Experienced Management: BXPHARMA's management team is seasoned and experienced (15.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Iqbal Ahmed
MD & Director39.9yrsno datano data
Mohammad Ullah
Company Secretary & Executive Directorno datano datano data
Salman Rahman
Vice Chairmanno datano data2.04%
BDT 771.8m
Abu Bakar Rahman
Director31.9yrsno datano data
Osman Chowdhury
Directorno datano datano data
Ahmed Sohail Rahman
Chairmanno datano data2.03%
BDT 770.0m
Quamrun Ahmed
Non-Executive Director4.1yrsno datano data
Mamtaz Ahmed
Independent Non-Executive Director4.4yrsno datano data
Reem Shamsuddoha
Non-Executive Director4.1yrsno datano data
Md. Hosein Khan
Independent Director3.9yrsno datano data

4.3yrs

Average Tenure

64yo

Average Age

Experienced Board: BXPHARMA's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 06:17
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beximco Pharmaceuticals Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Md. IslamBRAC EPL Stock Brokerage Ltd
Asif KhanEDGE Research & Consulting
Lorenza CastellonEquity Development Limited